Article
Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing…
bioRxiv: the preprint server for biology · 2022 · Zhiqiang Ku, author Xuping Xie, author Jianqing Lin, author Peng Gao, author Abbas El Sahili, author Hang Su, author Yang Liu, author Xiaohua Ye, author Xin Li, author Xuejun Fan, author Boon Chong Goh, author Wei Xiong, author Hannah Boyd, author Antonio E. Muruato, author Hui Deng, author Hongjie Xia, author Zou Jing, author Birte K. Kalveram, author Vineet D. Menachery, author Ningyan Zhang, author Julien Lescar, author Pei-Yong Shi, author Zhiqiang An, author
Key facts
| Title | Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth |
|---|---|
| First author | Zhiqiang Ku, author Xuping Xie, author Jianqing Lin, author Peng Gao, author Abbas El Sahili, author Hang Su, author Yang Liu, author Xiaohua Ye, author Xin Li, author Xuejun Fan, author Boon Chong Goh, author Wei Xiong, author Hannah Boyd, author Antonio E. Muruato, author Hui Deng, author Hongjie Xia, author Zou Jing, author Birte K. Kalveram, author Vineet D. Menachery, author Ningyan Zhang, author Julien Lescar, author Pei-Yong Shi, author Zhiqiang An, author |
| Journal | bioRxiv : the preprint server for biology |
| Published | Feb 16, 2022 |
| DOI | 10.1101/2022.02.01.478504 |
| Devices mentioned | K982382 |
| Product codes mentioned | CFN, DEW, KDT, MZF |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1